Stage Ii Pancreatic Cancer: Disease Bioinformatics
Pancreatic Cancer is an aggressive and quickly spreading disease where few symptoms exist until the cancer is very advanced, thus, pancreatic cancer has a poor prognosis even with early detection. It occurs when malignant cells form in the tissues of the pancreas, typically in the exocrine cells (the cells that produce digestive juices). Pancreatic cancer typically affects individuals who are African American, who are overweight, have diabetes, smoke, have pancreatitis, or have a family history of pancreatic cancer. Treatments for pancreatic cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials. Stage II pancreatic cancer is divided into two parts. Stage IIA is when the tumor is growing outside the pancreas but has not spread to lymph nodes, distant locations, or large blood vessels. Stage IIB is when the tumor has grown outside the pancreas and to nearby lymph nodes but not into large blood vessels or distant locations.
Stage Ii Pancreatic Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Pancreatic Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 321 products for the study of Stage Ii Pancreatic Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.